The 12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC) considered the topic of methodologies for determining human and ecosystem susceptibility to environmental hazards. The report prepared at the meeting describes measurement of susceptibility through the use of biological markers of exposure, biological markers of effect, and biomarkers directly indicative of susceptibility of humans or of ecosystems. The utility and validity of these biological markers for the study of susceptibility are evaluated, as are opportunities for developing newer approaches for the study of humans or of ecosystems. For the first time a SGOMSEC workshop also formally considered the issue of ethics in relation to methodology, an issue of particular concern for studies of susceptibility.
metabolic activation or detoxification of environmental toxins, and genes controlling the repair of DNA or cellular damage. Epigenetic changes in expression of these genes can also affect host susceptibility. These alterations may be due to inherited differences in genes that control the expression of other genes, to past environmental exposures, to the physiological state of an individual, to age-related differences, or to developmentally controlled processes. The interaction between genes and the environment, the cross talk between genes, and the interplay of environmental factors, which include diet and lifestyle, illustrate the complexity in understanding the susceptibility to environmental hazards.
Recent advances in the understanding of molecular biology, the human genome, toxicology, and disease mechanisms and ecosystem functions have led to significant advances in the study of susceptibility factors for environmental hazards. These methods can be used to identify environmental causes of human diseases and harm to ecosystems; to identify susceptible subpopulations; and to understand interindividual and interethnic differences in response to environmental hazards, which, we hope, will lead to disease prevention, an important translation of molecular medicine. The complex interplay between genes and environment represents a tremendous challenge to scientists but also an important opportunity to reduce the burden of disease and dysfunctions to humans and the ecosystem.
The number of biomarkers available to study responses of biological systems to environmental factors is growing rapidly. The term "biomarker" is a general term for specific measurements of an interaction of a biological system and an environmental agent (1, 2) . Biomarkers of exposure measure an exogenous substance or its metabolite and its interaction with a biological molecule. Because a number of factors determine whether a chemical exposure reaches its biological target for a toxic response, the most accurate measurement of "dose" is the biologically effective dose at the target tissue, which can be more reliably measured by biomarkers of exposure than estimated by measurements of administered or ambient chemical exposure.
Biomarkers of effect are measurable biochemical, physiological, behavior, or other alterations within an organism (1) . with adverse effects, although the level of evidence varies for the relationship between a given measured effect and specific, pathological responses, which occur often after a long period and after chronic exposures.
Biomarkers of effect
There is an overlap between biomarkers of exposure and biomarkers of effect, because the same biomarker can be used for both measurements. Some of the same biomarkers are also used to measure interindividual differences in response and thus further serve as biomarkers ofsusceptibility.
There is a continuum between biological markers of exposure and those of effect ( Figure 1 ). Exploring the relationship between biological markers on this continuum can be a useful means for detecting susceptibility. Biological markers of susceptibility can be defined as indicators of the mechanistic processes that cause variability among the compartments in the continuum between exposure and effect.
As a simplification, there are five different mechanistic avenues through which factors affecting susceptibility can influence the interaction between biological systems and environmental exposures. These avenues are body uptake, metabolism, target cell uptake, subcellular or molecular interaction, and the baseline status of the individual or ecosystem. The mechanistic avenues are bounded by compartments in which exposure or effect can be quantitated. These compartments are external exposure level, internal exposure level, extracellular level of toxic agent or metabolite, cellular level of toxic agent or metabolite, target cell toxicity, and adverse effect to the individual or ecosystem. In each case one or more of the mechanisms responsible for susceptibility produce a variation in the relation between compartments that is potentially detectable through use of biomarkers.
In the simplest formulation, susceptibility can be defined as a variation in the quantity of exposure/effect in a compartment among individuals or populations who have similar levels of exposure/effect in the preceding compartment. Of necessity, this can only be accounted for by mechanisms operative in the avenue between these two compartments. Examples of compartments and mechanistic avenues are the following: * For a given level of external exposure, there is an interindividual variation in the uptake into the body (e.g., increased Fe uptake in hemochromatosis; variations in uptake of air pollutants related to respiratory rate). * For a given level of a toxic agent, there is interindividual variation in the uptake into the target cell (e.g., increase in radioactive iodine uptake into the thyroid in iodine-deficient individuals; tumor resistance to chemotherapeutic agents). * For a given level of uptake into the body, there is interindividual variation in the level of a metabolically produced active toxic agent (e.g., differing activities of metabolic enzymes). * For a given level of uptake into the target cell there is a variation in the extent of effect (e.g., glucose 6-phosphate dehydrogenase deficiency or methemoglobin reductase deficiency rendering the red cell susceptible to oxidant stress; differences in DNA repair). * For a given level of effect in the target cell, there is a variation in the impact on the individual (organ functional reserve capacity variations due to age; disease factors).
* For a given level of effect in an organism, there is a variation in the impact on communities and ecosystems (e.g., shifts in biomass, species diversity, energy cycling due to heavy metals or organochlorines). Each mechanistic avenue can have multiple inputs in different directions, which influence the extent to which a quantity in one compartment affects the quantity in the next compartment. For example, even when the relation between the absorbed dose of a xenobiotic and the level of a toxic metabolite is the result of a single enzyme, the activity of this enzyme in any individual may be a function of a genetic polymorphism as well as the presence of other pollutants or of dietary factors that affect enzyme activity. The potential order of the compartments may differ depending upon the mechanistic pathways; e.g., metabolism may occur in a nontarget cell and precede uptake of the toxic metabolite into the target cell (reversal of the second and third sections in the above example). The relationship between compartments can be modeled mathematically so as to explore the extent of variability in the relationship between two compartments among a specified population group, i.e., the distribution of susceptibility due to this particular mechanistic avenue.
In essence, the true distribution of susceptibility in a population is the relation between the first compartment and the last one-between external exposure and disease outcome, with the intervening mechanistic avenues contributing to this distribution. For a given individual it is possible that a mechanism that increases susceptibility to a disease outcome in one avenue may be counterbalanced by a mechanism that decreases susceptibility in another avenue. It is thus important to recognize that analysis of only one mechanistic avenue in the pathway between exposure and disease does not necessarily provide definitive information on the susceptibility of any single individual in the population.
Biomarkers can be divided into those that measure compartments, e.g., blood levels, DNA 
Genetic Susceptibility
Individuals may vary in terms of their responses to environmental hazards due to differences in their genetic constitution. The human genome encodes for 50 ,000 to 100,000 genes, some ofwhich are key regulators of biological processes. Mutations (heritable alterations in the primary coding sequences of genes or their controlling elements) in specific genes ("disease genes") greatly predispose an individual to a disease. For example, mutations that inactivate the retinoblastoma gene, a central regulator of cell growth and division, can result in a 105-fold increased probability of a rare eye cancer in children (retinoblastoma). Due to recent advances in gene mapping and isolation, a number of major disease genes have been discovered, including genes involved in cystic fibrosis; Huntington's disease; Alzheimer's disease; and breast, colon, lung, and many other cancers. Mutations in disease genes lead to a very high probability of disease development, often approaching a 100% incidence of disease in carriers of the mutations.
Mutations in disease genes are usually rare; depending on the gene, 1 in 200 to 1 in a million people are affected. However, multiple genes may regulate a specific disease, therefore, the percentage of disease cases for which there is a genetic component may be high. For example, in certain cancers (e.g., colon, breast, and prostate) it is estimated that up to 10% of the cancers are due to a genetic predisposition. These very strong susceptibility genes may not be influenced by environmental factors, but there is evidence for environmental influences in some diseases even with a strong genetic predisposition.
Many of the genes in the genome of humans and other species influence the impact of environmental agents on the organism. Genetic controls on the uptake, activation, detoxification, or repair of environmental insults are known. The exact number of genes involved in the organism's response to environmental hazards is unknown but could be very large. For example, the estimates of the number of the individual P450 genes in any mammalian species range from 60 to 200 (3) . All Recent advances in the identification and cloning of specific genes and methods for the detection of mutations and polymorphisms in these genes have led to significant advances in our understanding of genetic susceptibility to environmental hazards. There is an important difference between individuals with genetic alterations that lead to disease susceptibility and individuals with genetic susceptibility to environmental factors. Individuals who inherit a mutation in a disease susceptibility gene have a high risk of developing that disease regardless of environmental exposures, although environmental factors may increase the incidence or rate of disease development. Individuals who have a mutation or polymorphism in genes involved in response to environmental hazards will only have an increased risk of disease development when they are exposed to specific environmental hazards. Therefore, risk to these individuals is influenced strongly by gene-environment interaction. Also, because multiple genes are involved in response to the same environmental hazards, two individuals with the same genetic susceptibility and environmental exposure may have different risks because of the interplay between genes involved in response to xenobiotics. For example, two individuals may both have a polymorphism in a gene that increases the rate of carcinogen activation but different polymorphisms in a gene that inactivates the same carcinogen. Because many environmental response genes remain to be identified and characterized and because many mixtures of environmental exposures are present in the environment, it is difficult to determine an individual's risk. Great biomarkers of exposure and effect that are applicable across a broad range of species that range from invertebrates to birds and mammals. However, ecologists also are concerned with understanding and predicting-through the use of biological indicators-differences in susceptibility of communities and ecosystems. Here, vulnerability refers to changes in the structure and function of ecosystems. The challenge for ecologists is to develop a broad range of methodologies from molecular through ecosystem measures that can be used to assess susceptibility.
In many cases, cellular and molecular biomarkers that can be used to assess the susceptibility of a range of indicator species will be most useful for communities and ecosystems as well. Such biomarkers could be used to assess both the health of the ecosystem and the potential of the ecosystem to support human populations and provide ecological services. Ethics The study of susceptibility in human populations and in ecosystems poses a number of ethical challenges. Regarding humans, both the manner in which information is obtained and the uses to which it could be put raise urgent concerns. Regarding ecosystems, the ethical duty to work towards protecting our shared environment and its life support systems requires ongoing attention and the development of clear guidelines.
Specifically relevant to susceptibility studies in humans is the sensitivity of the information and the likelihood of labeling certain individuals or subgroups in ways that could cause unanticipated harm. Scientists and public health professionals investigating susceptibility or implementing related preventive screening programs must be aware of the potential for harmful social and psychological side effects arising from susceptibility studies. For example, denial of employment, denial of insurance, fear for the premature onset of illness or death, social marginalization, reconsideration of family planning and of both medium and longer term life goals, and the need for psychological counseling are possible untoward effects that may arise from the identification of susceptibility in individuals.
Scientists also must remain sensitive to cross-cultural differences in perception of personal risks associated with susceptibility studies and must strive for equity in their research and in its potential consequences. For example, there may be greater need to focus resources on populations subjected to more severe pollution than on those populations experiencing lower levels of exposure.
Scientists must understand ethical issues to be able to address the challenges presented by susceptibility studies and to learn how to resolve them. Preparation would include defining the or the activity of 6-ALA dehydratase are all effects caused by lead; the inhibition of enzymes in the heme synthesis pathway results in anemia, yet anemia is rarely the end point of concern in lead poisoning, especially in adults. Thus, they are useful as exposure as well as effect markers.
A major criterion for distinguishing markers of exposure from markers of effect is the purpose to which they are put. In many cases enzymatic or cellular damage markers are used for dose reconstruction or for the classification of exposure status for epidemiologic studies. Van Schooten et al (9) , for example, treat DNA adducts in smokers as a means of estimating their polycyclic aromatic hydrocarbons (PAH) exposure.
For the purposes of this discussion we recognize the following as biomarkers of exposure: a) measurement of the xenobiotic itself (i.e., lead in blood, DDT The past decade has seen the development of in vivo X-ray fluorescence (XRF) of bone as a way of measuring the relative concentration of lead stored in the skeleton. Although increasingly available, the technique is still under development, and there is not adequate concordance among laboratories (18) . Two types of machines are used, the K-wave and L-wave sources, which differ in their penetration and apparently in the precision of measurements. Almost all machines in use today employ K-wave XRF.
An example of using blood lead as a marker of exposure and susceptibility is a recent study in Mexico. Romieu et al. (19) found a significant correlation among the lead content of ceramics used to prepare food, the soil lead on children's hands, and the children's blood lead; yet all of the environmental variables explained only 19% of the variance in blood lead. Thus even assuming that there are uncertainties in measurement of the independent variables, this leaves tremendous room for individual variability in the uptake and distribution of inorganic lead in these children. Thus blood lead identifies variation in susceptibility as well as exposure among these children.
Analysis of lead in urine is of relatively little value for quantifying exposure, even in those with organolead exposure.
Many studies have shown that there is a low correlation between lead in blood and lead in air, due in part to the sampling duration; concurrent exposures through water, diet or other jobs; alternative routes of exposure (ingestion); variations in the use of protective equipment; variations in circumstances of exposure, including respiratory rate, exercise, and other microniche characteristics; and individual variation of either a genetic or epigenetic nature (17) .
MERCURY. The uptake, toxicokinetics, and end points associated with organic mercurials (particularly methyl mercury) differ greatly from those associated with inorganic mercurials. Inorganic mercury is excreted mainly in urine, organic mercury mainly in feces. Both mercurials can be deposited in hair. Accordingly, inorganic exposure is usually monitored with urinary mercury, although blood mercury testing is also useful and helps distinguish exposure within the past week from that occurring in the past month. Blood mercury is used to assess organic mercury exposure. When dietary exposure (especially fish consumption) is the source of mercury, it is usually not necessary to speciate the mercury, since almost all of the mercury is methyl mercury. There is a strong correlation between either blood or urine mercury and air mercury (20) .
Hair mercury is useful for screening populations. The digestion of hair, however, causes difficulties in some laboratories (21 (27) , of p-nitrophenol after exposure to parathion and methylparathion (28) , and of 1-naphthol after exposure to carbaryl (29) . Altered liver enzyme activities have been reported among pesticide workers exposed to organophosphorus pesticides alone or in combination with organochlorine or other pesticides (30) . Monitoring changes in vitamin K levels is useful for identifying exposure to anticoagulant rodenticides (31) .
Adducts to hemoglobin have been detected with several pesticides (32) . The advantages of such measurements include the possibility of assessing dose closer to the target, of assessing individual capacity to form electrophiles, and of extrapolating data on toxicity more easily across species. When the mechanism of action of a pesticide is understood, more specific markers can be used (30 (21, 34) .
Further markers in pesticide application workers are described by Anwar (26 of biomarkers at these levels in almost all systems of the body, induding biomarkers of hematological toxicity, nephrotoxicity, hepatotoxicity, immunotoxicity, neurotoxicity, pulmonary toxicity, and reproductive and developmental toxicity (1). These will not be considered further here, but rather this review will focus on biomarkers of effect at the subcellular level, particularly at the chromosomal and molecular level, which are particularly useful in assessing susceptibility. These include biomarkers at the genomic level, such as cytogenetic alterations and gene mutations, and biomarkers of gene expression, such as messenger RNA and proteins. Some assays of protein function, such as enzymatic activity, could be included in this category but could a,lso be considered as biomarkers of exposure (e.g., cholinesterase activity in response to OP exposure), and thus they will not be included here. Biomarkers at the genomic level or at the level of gene expression have been most strongly associated with the risk for cancer, although in selected instances they may also be associated with other disease end points. Therefore, in general, we will be concerned here with subcellular biomarkers of effect that are believed to be associated with cancer. We will examine the methodologies employed with reference to the objectives of their use, their potential uses, and their advantages and limitations.
Because in many instances, these biomarkers of effect are believed to represent events in a causal pathway to disease, their occurrence may be viewed as indicative of an acquired susceptibility for that disease. This is in distinction to the biomarkers of susceptibility per se, which in many cases represent indicators of inherited susceptibility to disease due to their influence on steps in the causal pathway. Biological markers of effect, as indicators of acquired susceptibility for disease, have the theoretical potential to exhibit predictive value in identifying individuals who could develop disease at some point in the future or in determining the likely disease progression in terms of severity and prognosis once disease has occurred. In addition, biomarkers of effect, because they occur quite far along the pathway between exposure and disease outcome, essentially provide an effective integration of the influence of biomarkers of susceptibility for all preceding steps in the causal pathway and are thus a summary marker for susceptibility to that point.
Cytogenetic Markers
In humans, cytogenetic alterations are most often analyzed microscopically from peripheral lymphocytes after they have been stimulated to divide in culture by a mitogen (40) . Lymphocytes are used as a surrogate for the actual target tissues of genotoxic carcinogens. Some cytogenetic end points (micronuclei, numerical aberrations) can also be studied in interphase cells from target tissues or proximate target tissues, such as exfoliated cells from buccal, nasal, urothelial, bronchial or esophageal epithelium (41, 42 semen specimens (43) . Fresh samples are required in most cases, but preservation by freezing or fixation is possible for several of the cytogenetic techniques. The analysis of cytogenetic end points from such samples is used to show exposure to genotoxic carcinogens and may have value in the identification of groups of people at increased risk of cancer (44, 45) . Cells from different individuals can be challenged with genotoxic agents in vitro, which in some cases may enable the recognition of sensitive individuals (46, 47) .
Chromosome Aberrations. Chromosome aberrations (CAs) are structural alterations, breaks and rearrangements, in chromosomes, usually observed in metaphase-blocked cells using conventional microscopy (40) . Chromosome-type rearrangements, such as translocations and dicentrics inspected in biological dosimetry of radiation, can also be analyzed using chromosome painting based on FISH with chromosome-specific DNA probe libraries (48) . This approach has enabled the recognition of new types of complex chromosome rearrangements that have not been detectable with conventional cytogenetic techniques. Recently, a simplified FISH method to detect chromosome breakage and alterations of chromosome number, using tandem DNA probes specific for a region in chromosome number 1, was reported (49) . FISH has also been applied to study numerical chromosome aberrations of specific chromosomes (50) . Polymerase chain reaction (PCR)-based methods for the analysis of lymphocytespecific illegitimate chromosome recombination involving human immunoglobulin or immune receptor loci and considered to reflect genetic instability have also been described (51, 52) . In two recent, independent reports, increased rates of CA in peripheral lymphocytes were shown to be associated with later development of cancer (44, 45) . Thus, the analysis of CAs is presently regarded as the cytogenetic method of choice in studies of human exposure to genotoxic carcinogens. In vivo inducers of CAs in humans include, among others, ionizing radiation, alkylating cytostatics, tobacco smoking, benzene, and styrene. Besides smoking, factors such as age, gender, and diagnostic and therapeutic X-rays are usually taken into account as possible confounders. In vitro challenging of lymphocytes from healthy individuals with genotoxins has revealed individual differences in CA response to some genotoxic agents (53, 54) . The reasons for such differences are unknown, except for 1,2:3,4-diepoxybutane, where an association probably exists with the deficiency of glutathione S-transferase TI (GSTT 1) (46, 47, 55) . Among butadiene-exposed chemical workers, GSTTI null individuals also had an elevated rate of chromosome aberrations in peripheral lymphocytes in vivo (56) . On the other hand, the lack of GSTM1 has been associated with elevated CA frequencies in smokers and in bus drivers (57) .
Sister Chromatid Exchanges. Sister chromatid exchanges (SCE) represent symmetrical exchanges of DNA segments between the sister chromatids of a duplicated metaphase chromosome (58) . In lymphocytes of humans, tobacco smoking, alkylating cytostatics, and ethylene oxide are well documented SCE inducers. Factors to be controlled in the analysis of SCEs include age, gender, and life style. Individuals with enhanced in vitro SCE response to some genotoxins have been described and, in some cases, this has been associated with certain metabolic genotypes or phenotypes (46, 47, 50, (59) (60) (61) (62) (63) (64) (65) (66) . For example, individuals sensitive to in vitro SCE induction by 1,2:3,4-diepoxybutane were recently found to be deficient of GSTT1 (46, 47, 62, 64, 66) . Such people also show elevated baseline frequencies of SCEs in their peripheral lymphocytes (47, 62, 67) . SCEs were not, however, elevated in GS7TJ null individuals exposed to butadiene (62) .
Increased SCE rates have also been indicated in relation to the GSTMJ null genotype and smoking (68) and deficiency of the low Km aldehyde dehydrogenase and alcohol consumption (69) .
Micronuclei. Micronuclei (MN) are small additional nuclei observable in interphase cells. Micronucleus induction can be triggered by either clastogens or agents that influence the mitotic apparatus, such as spindle poisons (70, 71) . Micronuclei can also be scored in exfoliated cells of buccal, nasal, or urothelial mucosa (41) . The presence of whole chromosomes in MN can be checked by identifying centromeric DNA sequences (using FISH) or kinetochore proteins in the MN (72, 73) . In vivo, increased MN frequencies in lymphocytes have been associated with exposure to ionizing radiation, aging, and gender (74) . In women, the influence of age on the frequency of MN in lymphocytes has been relate,d to an increased inclusion of the Xchromosome in MN (75, 76) , while in men the Y-chromosome appears to be responsible for a part of this effect (77) . In buccal or nasal mucosa, MN induction has clearly been shown for, e.g., various ethnic chewing habits (3) and exposure to formaldehyde (78) . The MN analysis has given negative results in several studies in which another biomarker of genotoxic exposure has been positive. As MN can originate from chromosomal fragments and whole chromosomes, the number of cells presently examined may not be enough to reveal the relatively small effects usually expected in exposed humans. (79) . Studies of human lymphocytes in vitro are also considered useful, as they provide information on HPRT mutation spectra obtained after exposure to specific carcinogens in controlled conditions. Several studies have been carried out on HPRT-mutant lymphocytes in human populations exposed to various genotoxic agents, as reviewed by Cole and Skopek (80) and briefly described by Hemminki (11) . Only a few studies have thus far tried to correlate HPRT mutations with other measures of exposure and susceptibility. In a study of occupational exposure in a foundry, the frequencies of HPRT-mutant T-lymphocytes correlated with the level of aromatic DNA adducts (81, 82) . In a recent study on garage workers, a correlation was found between aromatic DNA adducts and mutation frequency at the individual level; genotypes of two xenobiotic-metabolizing genes (GSTMI and NAT2), alone or combined, did not influence HPRT mutation frequency (83) .
The glycophorin A (GPA) assay is another in vivo method for the detection of somatic mutations to study the potential effects of exposure to chemical and physical mutagens (84, 85) . The assay is based on the autosomal GPA locus that encodes the cell surface sialoglycoprotein expressed in the erythrocytic lineage and responsible for the M,N blood group. It uses immunolabeling and flow cytometry to enumerate, in peripheral blood samples of M/N heterozygotes, erythrocyte variants reflecting mutations in the GPA locus. Most of the variants are considered to derive from mutations that occurred in bone marrow stem cells and are therefore permanent, depicting lifetime accumulation of mutations. The GPA assay has been automated and is thus easy, fast, and cheap to run. The main limitations are that only one half of the human population (M/N heterozygotes) can be studied and an expensive flow cytometer is required. As erythrocytes have no nuclei, the variant cells cannot be clonally expanded and the mutations cannot be characterized at the molecular level.
Both the HPRT and GPA mutation assays show a small number of people with exceptionally high mutant frequencies in healthy subjects (86) . While at least part of such high frequencies are due to clonal expansion of a few original mutations, some of them might indicate individuals of enhanced susceptibility. In a study of GPA mutations in reinforced plastics workers, the high frequency individuals were primarily smokers or ex-smokers (87 Mutations in oncogenes and tumor suppressor genes are most common in many types of human cancer. In the context of external exposure to carcinogens, the ras genes have been shown to be mutationally activated in a number of environmental cancers in humans (89) , and. in a carcinogen-specific manner in animal studies (90) . Since the p53 tumor suppressor gene is among the most frequently altered genes in human cancer, molecular analysis of its mutational spectra has been used as a clue to cancer etiology and mechanisms of carcinogenesis (91, 92) . In the p53 gene, DNA sequences corresponding to the highly conserved domains of the protein have been identified as a "hot spot" region for mutations. A majority of mutations identified in these genes in human cancers are missense mutations, making them suitable targets for such analysis. The exposure-related nature of p53 mutations has been proposed in many studies on various forms of human cancers (91) (92) (93) (94) . Wellknown examples of this are nonmelanoma skin cancer associated with exposure to sunlight (UVB) as well as hepatocellular carcinoma related to dietary exposure to the mycotoxin aflatoxin B1 (AFB1) (92) . With the highly sensitive mutation detection assays it has been possible to investigate whether the suggested causative carcinogens (AFB1, UVB) induce similar kinds of mutations in human cells in vitro. In the case of AFB1, the results were in agreement with the etiological role of AFB1, although other types of mutations were also seen (95) . In nonmalignant human liver tissue, the frequency of the specific AGG to AGT mutation at codon 249 was found to parallel the level of AFB1 exposure in the geographical areas where the patients lived (96) . For UVB exposure, the experimental work on human skin fibroblasts did not find the tandem double CC to TT mutations seen frequently in skin cancer (97) . A relationship between certain types of ras mutations or p53 mutations and occupational exposure to agents like solvents, vinyl chloride monomer, some bladder carcinogens, and radon has been suggested (98-100). In addition, smoking has been associated with increased prevalence ofp53 mutations in some tumors, and certain types of base substitutions have been linked with exposure to tobacco smoke (101, 102) . Recently, two studies have reported a higher frequency of p53 mutations in lung cancer patients with the at risk genotype of GSTMI gene (103) (104) (105) (109, 110) . It is also well suited for detection of polymorphic alleles of various genes (109) . DGGE separates DNA molecules based on their sequence-determined ability to melt (separate partially) in longer fragments (low-and high-temperature melting domains) (111) . DGGE separates physically wild-type DNA from mutant molecules, and under appropriate conditions all single-base substitutions, frameshifts, and deletions less than about 10 bp can be resolved from the wild-type DNA (112) . DGGE, or its application called constant gradient gel electrophoresis (CDGE) (113) , has been used to study both germline and somatic mutations in many human genes. These include mutations in cancer-related genes, human ras and p53 genes, as well as chemically induced mutations of HPRTgene in human lymphocytes in vitro (112) . More recently, a capillary electrophoresis technique has been applied for CDGE (114) .
For detection of known mutations in certain sites of a gene, two much-applied methods include allele-specific oligonucleotide hybridization and genotypic mutation analysis by restriction fragment length polymorphism (RFLP)/PCR method. Allele-specific oligonucleotide hybridization uses labeled probes which are hybridized to PCR-amplified genomic DNA. It has especially been used in studies on ras gene mutations in various human cancers (89, 115 DNA sequencing based on dideoxymediated chain termination reaction (118) can be performed also after in vitro amplification of the DNA template by PCR. Direct sequencing of PCR amplification products is thus one method of choice for mutation analysis; it is perhaps more labor intensive when performed manually but has been automated (119) . Methods using solid phase support in sequencing are being used increasingly (120 effects. Could such an impairment/disability be compensable under tort or workers' compensation laws? Would such an individual be entitled to special considerations under laws for protecting the disabled in employment and other societal circumstances? Prior to the general use of biomarkers of effect, such questions will have to be addressed. Some general ethical aspects of these issues are considered in more detail elsewhere in this volume.
Other potential uses of biomarkers of effect are in monitoring of disease progression and prognosis, and as adjuncts to other biomarkers in providing refinements of epidemiology and risk assessments. At the very least, biomarkers of effect, as well as other biomarkers, offer the opportunity to provide scientific confirmation of proposed exposure-disease pathways in vivo in human populations. Biomarkers of effect may be particularly useful for demonstrating the biologic influence of preceding susceptibility factors (e.g., genetic polymorphisms of xenobiotic-metabolizing enzymes). It should be noted once again, however, that at this time these biomarkers of effect should only be employed in the context of carefully designed studies with all due attention to the rights and concerns of the human subjects involved. Nevertheless, we believe that research on biomarkers of effect is worth pursuing because of the potential benefits for disease prevention.
Biological Markers of Susceptibility
Definition ofSusceptibility Markers A biomarker of susceptibility is defined as an indicator or a measure of an inherent or acquired ability of an organism to respond to the challenge of exposure to a specific xenobiotic substance (1). Biomarkers of susceptibility are concerned with factors in kinetics and dynamics of uptake and metabolism of exogenous chemicals. Thus the concept encompasses enzymes of activation and detoxication, repair enzymes, and changes in target molecules for toxic chemicals. Many of the latter conditions include factors that confer highly increased risks to predisposed individuals (i.e., repair gene defects, "fragile" DNA conditions, etc.). Susceptibility factors occur along a continuum from "near-obligatory" determinants of high risk to contributory low risk factors (such as metabolic polymorphisms). In this document, we focus on those factors that involve a major contribution of gene-environment interaction to become manifest.
Monogenic traits are inherited in a Mendelian fashion. A genetic polymorphism refers to a monogenic variation that occurs with at least two phenotypes with sufficient frequency (> 1%) to cause population differences. Genetic variations occur as either germline inheritance or somatic cell mutations. Rare inherited metabolic diseases such as Crigler-Najjar syndrome occur as a germline mutation (132); a wellknown example of a somatic cell mutation is hepatocellular carcinoma caused by dietary exposure to AFBI (91) .
Nongenetic factors such as age and sex are obviously important but need further refinement in terms of molecular mechanisms and their interplay with environmental factors before being useful for any intervention. Acquired factors (for example physiological changes, disease-induced changes, induction and inhibition of enzymes by dietary factors, etc.) are also critical but difficult to study because of their individual nature. Such changes may not be permanent and thus may be impractical to take into consideration in any long-term or retrospective study.
Interindividual variability is observed for practically all diseases and toxic responses. It is certainly related in part to different qualitative and quantitative environmental exposures, but differences in susceptibility between individuals in response to the same level of exposure are also common. In most chronic diseases, a long sequence of events leads to a final response, which is seen as a result of an interplay of multiple genetic and other host factors and environmental factors, each contributing to an overall risk of having a manifest response.
Although biomarkers of susceptibility identify those individuals in a population who have a difference in susceptibility to the effects of chemical exposure, only in some circumstances can they predict an individual's risk with any confidence. It is important to not generalize inappropriately from in vitro evidence of susceptibility, as has occurred in inferring that individuals with red blood cell glucose 6-phosphate dehydrogenase deficiency are particularly sensitive to inhaled ozone (133 
Methodology in Studying Susceptibility-related Genes
The approaches and methods described in this section will focus on studies of polymorphisms in xenobiotic-metabolizing enzymes. However, most of these methods, in particular the molecular techniques, can be used for studying polymorphisms of other susceptibility-related genes, such as DNA repair enzyme genes or disease genes. In addition to the polymorphisms of susceptibility-related genes, other genetic alterations such as "mini-and microsatellites" are also believed to be important in human carcinogenesis and are involved in individual susceptibility (134) .
There are two important parts in studies of genetic polymorphisms. The PCR technology has greatly increased our ability to detect genetic polymorphisms. DNA amplification can be carried out with specific PCR primers for any particular sequence of a polymorphic gene, with small amounts of human tissue or cell samples. The DNA source can be from blood leukocytes, buccal epithelial cells, hair roots, and exfoliated cells such as bladder epithelial cells in the urine. The PCRamplified DNA sequence containing the polymorphic sites can be analyzed by RFLP with restriction digestion and visualized on a stained gel after electrophoresis. If the genetic polymorphism results in a loss, or in some cases a gain, of a restriction site, the band pattern on the gel will be different from the wild-type samples, such as in CYP2E1 polymorphisms (143) . If the PCR primers are designed to be within the missing sequence of a deletion polymorphism, no PCR product will be formed.
Obviously, the RFLP method cannot be used to screen the genetic polymorphisms in which the sequence alterations cause no changes at suitable restriction sites. In this case, genotyping can be carried out by creating a restriction site by mismatch primers (144, 145) or by allele-specific PCR (146) . If necessary, the results from PCR-RFLP and allele-specific PCR can be confirmed by PCR-direct sequencing (147 (161) . While rare mRNA transcripts can be detected by the RT-PCR approach, determination of relative or absolute copy number may be more problematic (162) 
Condusions and Recommendations
There are a large number of different methods to measure susceptibility factors, ranging from the activity of an enzyme to the detection of mutant alleles of a gene associated with a modified phenotypic trait. In an era of molecular biology, exceedingly sensitive and specific methods to detect alleles and expression of genes of interest have taken center stage; but one has to keep in mind that it is actually the phenotype that is of importance for the final response to the hazardous insult.
One serious problem in phenotyping studies is lack of knowledge of the levels of enzymes in the target cells and organs relevant to the whole body metabolism and the correlation of genotype with in vivo phenotype. In humans, practical considerations dictate to a large extent that one has to resort to surrogate tissues.
Genotyping has some advantages, such as unequivocal identification and lack of interference with confounding factors; but a modified sequence within a gene (polymorphism) must be demonstrated to generate a different phenotype.
In vivo phenotyping has the advantage in some cases of assigning a value with one assay that might require determination of multiple genotyping assays when several alleles are present in the population. In vivo methods to measure phenotype may lead to misclassification of different genotypes, which in the case of rare alleles can have a large effect on the frequency.
To fully exploit the genetics of xenobiotic metabolizing enzymes as risk assessment tools, much more information on the structure/function relationships and regulation of these enzymes correlated to the in vivo phenotype must be elucidated.
On the basis of the current knowledge of the field and of the above conclusions, the following recommendations are made: a) Phenotyping should be continued along with genotyping, until we gain experience with large numbers to enable interpretation of more complex relationships.
b) The combined impact of all relevant genes for a given exposure (as far as they are known) needs to be assessed through population-based studies using multiple markers. New insights into the physiologic function of genes encoding xenobiotic metabolizing enzymes will be revealed by studies of transgenic "knockout" or"insert" models.
c) Better kinetic characterization of enzyme substrate and inhibitor specificity must be determined through studies of human tissues, as well as through detailed metabolic studies of whole organisms. The future availability of crystal structure of drug metabolizing enzymes in combination with computational chemistry will provide better information on structure/function predictions. d) A greater understanding of the regulation of enzyme expression by environmental agents is needed.
e) (165) (166) (167) .
Among the hierarchy of biomarkers and biological indicators, representing pollutant-induced changes in biota at all levels of organization (from the molecular to ecosystem), lie the means to identify, classify, and ultimately quantify, the susceptibility of individuals and populations to the detrimental effects of chemical exposure. At The formation of DNA adducts has been considered a key step in the initiation of carcinogenesis. However, the presence of DNA adducts in aquatic invertebrates that rarely or never develop neoplasms may obviously be linked to genotoxic end points other than tumorigenesis. Based on good correlations between the induction of DNA adducts and gene mutations, it was hypothesized that, in natural species, a variety of manifestations of the mutational event may actually prove much more biologically and ecologically important than the induction of neoplasia (171) .
Strand breakage of DNA has also been used to study the effects of environmental pollutants. Although strand breakage can lead to cell death, in many cases it is repaired before serious damage occurs. Strand breakage as measured by the alkaline unwinding assay is one of a suite of biomarkers used to study the effects of pollution on the liver DNA of bluegill sunfish (Lepomis macrochirus) in rivers of the eastern United States (172) . The basic prerequisite for the successful use of DNA adduct and DNA strand breakage in environmental risk assessment studies, however, is the recognition of the fact that lower invertebrates may be incompetent in forming DNA adducts from some highly prevalent pollutants such as PAHs (173) .
Some indicators of chemical exposure and effects methods are shown in Table 2 .
Biological Indicators of Susceptibility at the Individual Level
The phenomenon of resistance is a striking example of differential susceptibility of organisms to environmental chemicals. There are a number of mechanisms whereby organisms can resist the action of toxic chemicals. These include decreased uptake, increased efflux, increased rate of metabolism of the toxicant, sequestration of the toxin, and increase or repair of target sites within the cell. In some cases more than one mechanism is involved and changes made against one chemical can protect against another; hence, the phenomenon of cross-resistance.
The factors that influence the onset of resistance fall into three broad categories: genetic, biological, and operational. In the first category is the frequency and dominance of the resistant gene. Dominance is important; if the gene is normally recessive because it has disadvantages, such as lower reproductive capacity, the greater the genetic disadvantage, the slower the resistant strain takes over. The shorter the generation turnover and the greater the number of offspring per generation, the more rapidly resistance can occur. For pesticide resistance, the operational factors include the actual pesticide used and the mode and area of application. It is in the area of disease resistance in insects that we have the greatest control (174) .
The degree of resistance can be large.
For example there are houseflies for which the LD50 for DDT is 3000 times normal, the main mechanism that defends the organism being increased levels of a dehydrochlorinase (175) . Resistance among vertebrates is not so evident, although it has been reported in several species of fish, and the case of warfarin resistance in rats is well known.
Resistance can cause considerable changes in the community structure of invertebrates. Man's attempts to control the pests that affect cotton in northeastern Mexico and the southern United States is a good example of the problems that occur with resistance and the alterations of community structure caused by differential susceptibility of organisms to environmental chemicals (176) . During the period 1945 to the mid-1950s there was almost complete control of the main pests-the boll weevil and the cotton fleahopper-by OC pesticides and there was a spectacular increase in cotton production. In the mid1950s it was necessary to switch to OP compounds which increased the costs but cotton was still profitable. Former minor pests, the bollworm and tobacco budworm (177) . The low expression of activity of P-glycoprotein, a dominant feature in the MXR mechanism (178) , in, for example, the snail Monodonta turbinata specimens living in a pristine marine environment, indicates high susceptibility for accumulation of xenobiotics and, consequently, higher likelihood of effects (179) . In contrast, specimens of snails living at polluted sites, expressing higher activity of P-glycoprotein due to its induction, are less susceptible to toxic effects of xenobiotics due to a lower level of its accumulation. Thus, the level of expression of MXR may be a good long-term indicator of susceptibility to chemicals. Similarly, species with high levels of MXR (P-glycoprotein) expression, such as mussels (Mytilus galloprovincialis, Mytilus edulis, Crasostera gigas) (180), clam (Corbicula fluminea) (181) , marine snail (M. turbinata) (179), marine worm (Urechis caupo) (182), or four marine sponges (183) , in contrast to a fresh water mussel (Anodonta cygnea) and a fresh water snail (Paludina vivipara) (179) (185) .
Several species or groups can be good indicator species. Very good bioindicators are the water insects, especially species and groups of species of the order Ephemerophera. Ecological niches and needs of their larvae are well known. By feeding on detritus they accumulate in their bodies xenobiotics that can be reliably identified (186) .
Behavioral Mechanisms. Individuals can clearly be exposed to chemicals in situations in which they cannot escape or move away from the exposure: then they must rely on biochemical detoxifying methods to avoid effects. Sessile organisms that make up most species in the aquatic world are unable to move away from exposure. However, many organisms, particularly vertebrates, have a number of behavioral and life-history strategies that enable them to avoid exposure to chemicals. These mechanisms make them less vulnerable or less susceptible to the effects of these chemicals.
The most obvious mechanism to avoid chemicals is to move away from exposure; and many animals do this by simply flying, swimming, or walking away. This mechanism functions in many species when they are exposed to high doses of chemicals such as occurs during an oil spill. Birds, many marine mammals, and fish will swim or fly from advancing oil when it is possible to do so (187) . However, other fish and some marine mammals will not do so until it is too late to avoid exposure. Most exposures to chemicals, however, occur at such low doses that animals do not, or cannot avoid them.
The impairment of locomotion or abnormal behavior of animals is being used to monitor pollutants. Fish have been used commonly--monitoring the frequency of coughing (188, 189) , loss of rheotaxis, or disturbance of schooling. These methods are linked with automatic water sampling systems to serve pollutant analysis. Direct measurement of respiration through blood vessels in fish was devised to monitor contaminants (190) . Monitoring of mussels' activity is also practical since mussels respond to hazardous chemicals by closing their bulbs. Abnormal web spinning by caddisfly larvae or failure to make nests by other aquatic insects are also useful methods to monitor pollutants. Feeding activity can be another biomarker. A short-cut test with Daphnia using toxicant-induced inhibition of feeding is being studied.
For showing the changes caused by long-term exposure, it is most important to observe changes in the populations of individual species. Changes in populations that are useful include the changes in population dynamics, fertility and fecundity, physiological resistance to external factors, behavior, levels of parasitism or pathogen infestation, and changes in the structure of communities of social insects (186 The low level of activity in fish has been considered to be due to the fact that until historical times this group of organisms has found the excretory route across the gills effective for removing most xenobiotics. It is clear that this mechanism is quite inadequate to deal with highly liposoluble organochlorine molecules that have been released into the environment by humans in the last few decades.
The relationship between feeding habits and MFO activity has also been demonstrated in insects. A detailed review of the data for aldrin epoxidase has been made by Brattsten (192) . He found that aldrin epoxidase activity is lowest in monophagous species, considerably higher in oligophagous, and some 10-fold higher in the most polyphagous species.
The comparison of Phase I and Phase II hepatic transformation in quail and trout to that of a number of mammalian species commonly used in toxicity testing has been made by Gregus et al. (193) . They found that the overall metabolism of xenobiotics could vary several hundredfold between species.
ToxicrrY OF DIOXINS. The toxicity of dioxins to various mammalian species varies greatly. The most sensitive species known is the guinea pig; the LD50 for the male is 0.6 pg/kg and the female 2.1 pg/kg, the value for the male rat is 22 pg/kg, for the female rat 45 pg/kg and for the rabbit (mixed sex) 115 pg/kg, whereas the least sensitive species is the hamster (1200 pg/kg) (194) .
EGGSHELL THINNING. The phenomenon of eggshell thinning, although confined to only one order (Aves) does illustrate some interesting points in susceptibility. Eggshell thinning is caused by DDE and the sensitivity varies greatly. A diet of only a few parts per million will cause 20% thinning (the degree of thinning that causes eggshell breakage and thus reproductive failure) in raptorial birds and some species of fish-eating birds such as the pelican and cormorant. Other species such as gull, terns, and ducks are only moderately sensitive with diets of 40 to 50 ppm being needed to cause biologically significant eggshell thinning. Still other species, such as quail and chicken are completely insensitive and it is impossible to achieve more than a few percent thinning even at the highest dosage that can be used without mortality. One important point from this variation is that the common test species are insensitive and thus even if the measurement of eggshell thinning had been included in test protocols for new pesticides this phenomenon would not then have been recognized. Another point is that the species exposed to the greatest amount of DDE, due to bioaccumulation, are those that are the most sensitive. DDE-induced eggshell thinning caused the decline of many species of raptorial birds, such as the peregrine falcon (Falco peregrinus) and european sparrow hawk (Accipter nisus) over wide areas of the northern hemisphere. These Several examples illustrate the use of implications of susceptibility at the population level. In salt marsh ecosystems of North America, salt marsh grass (Spartina alterniflora) is the primary producer; susceptibility of this species to specific chemicals, which results in lowered reproductive output, would have a greater effect on community and ecosystem structure than would susceptibility of other, less important plant species (195) . S. alterniflora is susceptible to PAHs from oil pollution; the sensitive vegetative propagules can be killed and the species may take years to recover. Similarly, differences in susceptibility to chemicals among species of algae in salt marsh communities would also have a critical effect on community and ecosystem structure since algae productivity is critical to the overall productivity of the animal communities in the marsh.
Equally important to remember when using cellular and molecular biomarkers as measures of the susceptibility of communities and ecosystems to chemicals, is that changes in molecular and cellular organization must have effects at the population level to be important for community and ecosystem structure.
In many cases, chemical, physical, and biological stressors occur together; and the communities and ecosystems must contend with them at once. Since communities and ecosystems are assemblages of organisms, and thereby are populations that make up the system and are responsible for the stability and repair of that system, the relative susceptibility of that system depends on the susceptibility of individuals and populations within the system.
Biological Indicators ofSusceptibility to Chemicals at the Community Ll
Within any community or ecosystem the species are not necessarily of equal importance with respect to the maintenance of stability. That is, some species have a keystone role (196) . Keystone species include species that provide key nutrients or energy at the lower trophic levels, or species that regulate competition and predation at the higher trophic levels. Where molecular and cellula'r biomarkers are used to indicate potential susceptibility differences among individuals or species, care must be given to select indicator species that have a key or pivotal role in community structure (197) . Chemical disruptions to species that are essential for either the structure or the function of the system will have a greater effect on the susceptibility of the ecosystem than those that are less critical.
Several measures of the structure and function of communities and ecosystems (Table 3) can be used to measure change (167, (197) (198) (199) (200) (201) . The degree of change in ecosystem structure and function that occurs is a measure of susceptibility. That is, if a community or ecosystem undergoes few changes in either structure or function in response to a chemical, biological, or physical perturbation, then it is relatively resistant or can be said to be less susceptible to the effects of a given chemical or class of chemicals.
The methods to evaluate community and ecosystem change are often costly and time consuming, but they can sometimes be used with less technology and equipment. That is, in places or situations where extensive molecular and cellular laboratory facilities are not available, the community and ecosystem measures outlined in Table 3   Table 3 . Methods to measure differences in susceptibility at the community and ecosystem level. Revised from Burger and Peakall (195) ; and several articles in this volume. Ease of measurement is scored on a continuum of 1 to 10, 1 being the easiest to measure, 10 the most difficult. bUsefulness for assessment is scored on a continuum, A being most useful, C the least useful or indicative.
can be effectively used to determine differences in susceptibility. On the other hand, where such laboratory facilities exist, some of these techniques can be used effectively as surrogates to determine whether individual reproductive potential is compromised, thereby affecting population levels, and by extension, community structure. Table 3 also gives an indication of the difficulties of each methodology, as well as its usefulness for evaluation of the effects of chemicals. One of the most detailed studies at the community structure level was made in Canada to determine the effects caused by acidification in an experimental lake situation (202) . In this study the pH of a poorly buffered lake in northwestern Ontario was reduced from pH 6.8 to pH 5.0 over 8 years. Fish populations started to collapse due to lack of reproduction when the pH reached 5.9, and there were marked changes in the phytoplankton composition although primary production was not decreased. At pH 5.6 thick mats of filamentous algae appeared, which persisted throughout the study. When the stable value of pH 5.0 was reached the species composition of phytoplankton was completely different although primary production remained high; no fish reproduction was occurring; crayfish, leeches, and mayflies were absent; but there was a considerable increase in chlorophyll and no changes in nutrient concentration were observed.
Cas Studies
Lead. Lead is an example ofhow biomarkers can be used at different levels of organization. Concentrations of lead in tissues such as blood, liver, and kidney are measures of exposure. Analysis of levels of lead and other heavy metals, however, is costly and requires technical knowledge and sophisticated equipment. However, 8-aminolevulinic acid dehydratase (6-ALAD) activity can also be measured in blood as a biomarker of exposure and effect (203) . It is a cheaper and easier method of analysis than of lead itself.
Additionally, the effects of lead can be measured with a number of neurobehavioral assays, since one of the primary nonlethal effects of lead is on cognitive, psychomotor, and other neural processes in both human (204) and nonhuman biota (205, 206) . Lead can cause mortality directly, or can cause lowered reproductive success through depression of clutch and egg size, mortality of embryos, depression of growth, and disruption of reproductive behavior in a variety of species, especially Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997 on birds, the work on which has been key (206) . There are differences in susceptibility among birds: seabirds such as gulls and terns are more susceptible than chickens, ducks, and passerines (207) (208) (209) . Lead shows the classic trophic level relationships with respect to vulnerability: species that are higher on the food chain have higher levels of exposure than those that are lower on the food chain (206) . However, susceptibility will also vary with such factors as developmental maturity at hatching, at least in birds. That is, lead disrupts parental recognition, making those species dependent on recognition (i.e., precocial birds) more susceptible to the effects of lead than species that do not depend on this recognition (210) . Humans are at a relatively high trophic level and clearly show effects of lead. These effects, especially the neurological and behavioral ones, are particularly apparent during development, and persist for many years in humans (204) .
Lead can also have disruptive effects at the population and community levels. The abnormalities caused by lead can reduce survival and lower reproduction success, resulting in lowered population levels for impacted populations (206) . The effects in humans have the potential to severely alter social structure and behavior of populations that are severely exposed (204) . As early as the 1 950s, Bellrose demonstrated that lead poisoning could depress population levels by differentially affecting those wounded by hunters, and the response was dose related (211) . Similarly, birds nesting along roadways are heavily exposed to lead from gasoline, while those in more remote areas are not. Animals near smelters are also heavily exposed through the aquatic food chain. By differentially affecting different species, the species composition of communities can be affected by lead, leading ultimately to changes in ecosystem structure. Because organisms higher on the food chain are more susceptible, this end of the system would be more affected.
While the mechanisms whereby lead affects hemoglobin formation (e.g., inhibition of 8-ALAD) are well known, the mechanisms disrupting neural systems, development, and behavior are not well established. These phenomena have been quantified, without clarifying the mechanisms. Phenomena include differences in cell growth and neuronal projections.
PCBs and Dioxins. The mechanism of action of PCBs, polychlorinated dibenzofurans (PCDFs), and polychlorinated dibenozo-p-dioxin (PCDDs) is considered to proceed via initial binding to a high affinity, low capacity cytosolic receptor protein. The identification of the Ah receptor (212) with stereospecific, high affinity binding to 2,3,7,8-TCDD was a key finding in bringing molecular biology into the realm of toxicology. Examining the toxicological and receptor binding data, Poland and Knutson (213) concluded that it was likely that these compounds exert their toxicity through the cytosol receptor.
The ability of specific PCBs, PCDFs, and PCDDs to induce the P4501 system is greatly influenced by the degree of chlorination and the chlorine substitution pattern. The most toxic PCBs are those that are unsubstituted in the ortho positions, i.e., 3,3',4,4'-tetrachlorobiphenyl (TCB), 3,3',4,4',5-pentachlorobiphenyl, and 3,3',4,4',5,5'-hexachlorobiphenyl, which allows the molecule to assume a co-planar configuration. There is a close relationship between aryl hydrocarbon hydroxylase (AHH) induction and body weight loss, and AHH induction and thymic atrophy, although the interactions of enzyme induction, receptor binding, and toxicological manifestations are very complex and our knowledge is far from complete.
Problems that have to be faced before one can use this approach for wildlife toxicological investigations in the field are extrapolations from species to species and extrapolations from cell culture to the intact animal. Brunstrom and co-workers have carried out studies on avian embryos. Marked differences were found in the sensitivity of the chicken, pheasant, turkey, duck, and gull (214) (215) (216) . They found that the pheasant was 50 times less sensitive than the chicken, and other species were even less sensitive. This emphasizes the difficulties of interspecies comparison since the chicken and pheasant both belong to the order Phasianidae.
The application of this complex biochemistry to field investigations has been based on expressing the complex mixtures of PCBs, PCDFs, and PCDDs as dioxin equivalents (TCDD-EQ). Based on their affinity for the Ah receptor, the activity of the individual congeners are assigned a value relative to the most active compound (2,3,7,8-TCDD) which is given a value of 1. These toxic equivalent factors are multiplied by their concentration to give TCDD-EQ for each compound. Although even the co-planar PCBs are a good deal less active than 2,3,7,8-TCDD, their concentrations are much higher and thus they contribute more than the dioxins to the total TCDD-EQs. Now it is possible to do the process in reverse and use the degree of enzyme induction to estimate the TCDD-EQs. This bioassay approach is rapid and inexpensive compared to the conventional chemical analysis by gas chromatography-mass spectrometry.
Good correlations have been found between TCDD-EQ of egg contents and both the reproductive success and incidence of deformities in fish-eating birds in the Great Lakes of North America. In terms of sensitivity, it is of note that the cormorant is some 20 times more sensitive than the Caspian tern (Hydroprogne caspia). In the most contaminated areas of the Great Lakes, the productivity success has been linked to population declines.
Ethical Issues and Ecosystem

Susceptibiity
There are at least three areas where ethical considerations impact methods evaluation for ecological systems: scientist versus all other stakeholder views, government actions and ecosystem vulnerability, and, the conflict between using biomarkers in ecosystems for understanding the ecosystem itself and using ecosystems as indicators for human health [see section on ethics below, and Soskolne (15) ]. Increasingly, the responsibilities of scientists toward stakeholders (including scientists) are obscure with respect to how well the methodologies actually measure the phenomena in question. It is unclear, therefore, how soon scientific "findings" should be released or made available, how stringent the criteria for acceptance of an effect must be (given the accuracy of the methods), and how to resolve conflicts between scientific viewpoints that develop as a result of methodology differences. There is a conflict between the use of biomarkers as indicators of ecosystem health for itself, compared to using these biomarkers only as indicators of human exposure. We would argue that both are important uses of biomarkers, and biomarkers should be developed that fit and evaluate the effects of chemicals in both. We have an ethical responsibility to preserve ecosystem integrity on a worldwide basis.
Condusions and Recommendations
The following steps should be undertaken to protect organisms, species, communities, and ecosystems: a) development of biomarkers at the cellular and molecular level that cross-cut taxonomic levels, including the vast diversity of invertebrates b) study of molecules and mechanisms conserved across the animal kingdom; these highly conserved mechanisms may also have implications for higher animals including humans c) development of biomarkers that integrate across all levels of biological organization because some chemicals may have a greater effect at lower trophic levels while others will be more apparent at higher levels d) development of biological indicators that identify ecosystems susceptible to chemicals e) Development of biomarkers that are rapid and inexpensive and thus capable of being widely used.
Ethical, Social, and Legal Issues Surrounding Studies of Susceptibility Intoducdon: Ethics as a Methodology Growing Attention to Ethics. Since the early 1980s, there has been a growing wave of concern about the ethics of studies on biomarkers of susceptibility (217) (218) (219) (220) (221) (222) (223) (224) (225) (226) (227) . Technological advances continue to challenge our sense of what may be deemed "right" and "wrong" or "morally appropriate." These concerns have escalated since the beginning of the 1990s .
Education in the formal theories, principles, and rules of ethics generally has not been an integral part of graduate training among risk scientists. Even though scientists have tended to focus on "the scientific method" in their work, there are prominent examples of concern with the ethical dimensions of their speciality (249) . Notions of "peer review" are well developed and mechanisms for achieving "informed consent" are firmly in place. However, the social consequences, including both potential benefits and harms, have been relatively neglected in many areas of science (250, 251) .
Utility ofEthies. A brief overview of ethical theories in relation to scientific technologies is provided, with special attention to their application in the field of biomarkers of susceptibility. It will be shown that the discipline of moral philosophy, like the scientific specialty areas comprising the risk sciences, provides us with methodologies for analyzing decisions (e.g., whether or not to implement a new technology) and a philosophical basis for our actions. In practical terms, ethical analysis provides us with the tools through which decisions we make can be tested against ethical theories (and their attendant principles and rules) as a basis for explaining or justifying (moral) actions (252) .
Ethical Theories and Principles. Analogous to other disciplines, ethical analysis has a theoretical basis. Stemming from each theory are principles and associated rules, providing a framework for ethical analysis. Empirical data then are testable against these theoretical frameworks. Several theories from the discipline of ethics warrant review in the context of biomarkers of susceptibility.
Deontology, a duty-based theory that specifies obligations to be upheld by members of the profession, is perhaps the most commonly evidenced ethical theory among health professionals. The "scientific ethic," in fact, is deontological (duty based), requiring of scientists, among other things, to be objective, honest, and unbiased in the use of appropriate methods related to their subspecialty area of practice. Physicians, too, are bound by duties that derive from the principles of autonomy (i.e., the right of the individual to make independent choices), beneficence (i.e., the obligation to do good), nonmaleficence (i.e., the obligation to do no harm), and distributive justice (i.e., social equity). The preeminent duty among physicians is to not cause harm to their patients. It is through this duty that the physicians' role extends to that of patient advocate. Autonomy, as more recently interpreted, extends to include involving the patient as a partner in decisions about care. Distributive justice is manifest in the principle of equal access to care, regardless of ability to pay. These brief glimpses of ethics relate to physicianpatient relationships (253) .
Other relationships among health professionals exist. For example, those engaged in public health have the community's interests to protect, and usually adhere more to the utilitarian theory of ethics requiring that the greatest good be done for the greatest number of people. This practice does not predude the indusion in public health of other principles such as autonomy, nonmaleficence, and equity. However, the libertarian ethic has less utility within public health because it holds the individual more important than the community.
The egalitarian ethic holds all community members equally important and upholds the principle of solidarity. It measures the well-being of the group by that of the least well off. As an example of the use of egalitarianism, the U.S. Clean Air Act sets regulatory standards to protect the most susceptible members of the population. The principle ofjustice that flows from the egalitarian theory provides for equal access to the process of susceptibility assessment; by the same principle, the environmental risks should be fairly distributed across social classes, ethnic groups, and races. Equal outcomes cannot be expected because of the nonegalitarian characteristics of inherited genetic traits. The egalitarian philosophy, however, would strive to compensate for those inequalities through biologically based treatment or by social means.
It becomes evident that, depending on the ethical theory that one draws upon, one can rationalize apparently disparate conclusions. This is where normative professional practices need to be defined as an aid to individual practitioners faced with dilemmas, ethical conflicts, or tensions among various principles deriving from the respective theories. The recently formulated ethics of postmodernism uphold the principle of social specificity. This implies that local, subjective, and sometimes fragmented narratives may be more appropriate in guiding the actions of both scientists and the community than traditional overarching or absolutist theories.
The relational ethic, for those more familiar with moral philosophy, provides a basis for making rational comparisons among the various theories. While it is often heard that "ethics are value neutral," in practice it is generally agreed that ethics are, in fact, value laden. Hence, relational ethics can be especially helpful for identifying the theories and principles most appropriate to the issues in studies of biomarkers of susceptibility.
Distinguishing between "Research " and "Practice. "A distinction needs to be drawn between the professional engaged in research and the professional engaged in clinical or public health practice. The latter is often governed by legal requirements especially in the area of public health practice where, for example, tensions can arise between the principle of autonomy (in terms of the right to privacy) and the public's right to know about, for example, a potentially contagious condition that requires isolation or quarantine.
Research (46) .
The recognition of individuals who are subjected to a potentially increased risk of cancer from this exposure poses the ethical dilemma common to much of the present development of biomarker applications: how to prevent susceptible individuals (particularly those occupationally exposed) from being exposed to these chemicals. In this context, a tension appears between the human right to work and the ethical principle of nonmaleficence. To (134) .
Amplification resulting in overexpression of coding genes is a regular phenomenon under certain circumstances (257) . The gene for metallothionein protects against heavy metals, and exposure to heavy metals can cause an induction and an amplification of this gene (258) . The subsequent increase of the protein therefore can be a biomarker for exposure to heavy metals like cadmium and mercury.
Of pathological importance is the occurrence of amplification particularly of nuclear oncogenes such as c-myc. Such amplification has been suggested as a biomarker of some prognosis value in breast cancer patients (259 amounts of life insurance and that, in turn, could cause an economic deterioration of the insurance system. Prior consideration of these possibilities might help society to focus on the risks associated with the adoption of technological advances.
Genetic Screening of Workers. The recognition that certain genetic polymorphisms could be identified in humans (e.g., hemoglobin S, G-6-PD deficiency, xlantitrypsin deficiency) and could be related to differential susceptibility, led Stokinger (262) to advocate their application in screening for so-called "hypersusceptible workers." Omenn (223) cautioned against the blanket application of such techniques as inadequately predictive of risk, and several critics have noted the importance of controlling workplace exposures instead of removing susceptible workers from the workplace (263) . Although unusually susceptible individuals would benefit from not being exposed to the agents that are likely to make them sick, this intent should not be used as an excuse to avoid reducing exposures in the workplace; nor can it be invoked to avoid taking differential susceptibility into account in risk assessment (264) . Moreover, none of the genetic screening programs thus far proposed are sufficiently predictive of risk. Hence, any exclusion by virtue of membership in a genotypic class would be discriminatory, at least under United States law.
The elimination of women of childbearing age from certain occupations is now deemed illegal in the United States and represents an example of what is essentially genetic screening; namely, the elimination of persons with a particular genotype (XX) without regard to their actual susceptibility status.
Ecological Ethics. The emission of harmful chemicals into the environment also should be considered from an ecotoxicological point of view. Particularly, the contamination of the environment with persistent chemicals like some chlorinated hydrocarbons and heavy metals can have serious effects on the ecosystem through bioaccumulation along the food chain. Organisms at the top of the food chain run the risk of acute intoxication, reproductive inability, and behavioral disturbances. These effects on the ecosystem are relevant for the preservation of biological diversity in accordance with the convention of biodiversity accepted by the United Nations conference on environment and development in Rio de Janeiro, 1992. But besides our moral obligation to take into account effects on the ecosystem and biodiversity, the monitoring of ecotoxicological effects often can have relevance to human health.
The human species is also at the top of the food chain and is often exposed in the same way as other species at this trophic level. The recent focus on chlorinated compounds like PCBs, DDT, and tetrachlorodioxin, because of hormonal effects, may serve as a further warning signal for human beings. The deontologic duty of humans to serve as stewards of the environment for their own self interest and that of future generations is highlighted in this context. This duty enhances the right to life of other species.
Ethical Components ofBiomarker Project Proposals
Parties responsible for biomarker studies need to ensure that the broad range of persons involved in the planning, implementation, and outcome of projects (the stakeholders) are provided the protection of explicit ethical principles under which a project will be conducted. Persons involved include the study participants, the beneficiaries (including both participants and nonparticipants), the community (special and general), those gathering the data (researchers and surveyors), employers, trade unions, regulators, sponsors, and other potential recipients of the results.
The ethical issues to be addressed include the following: * autonomy of the participant in participating, including fully informed consent * beneficence of the project for the persons and institutions affected * absence of maleficence toward the participants and institutions affected * assurance of justice ( b) The positive aspects of biomarker technologies must be emphasized without failing to recognize the potential for their misuse.
c) There is a need to continue research to produce better evidence concerning susceptibility markers while simultaneously protecting against any misuse of premature or tentative evidence.
d) The active participation of the public is to be sought in a partnership capacity to ensure the advancement of knowledge concerning biomarkers for identifying susceptible people and populations.
e) It must be recognized that science is imperfect. Uncertainty is inherent to the scientific method and varies as a function of the evolution of scientific knowledge.
f) The imperfections of science require humility on the part of scientists. Science is but one part of a number of inputs for decision making. g) For every decision that is made, the tension between risk and benefit should be considered.
h) Good science should be tied to good ethics and vice versa.
i) An 
